Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Other 24Gastrointestinal 23Endocrine 9Breast 9Lymphoid 7Other hematologic neoplasm 6Genitourinary 5Gynecologic 4Head & Neck 3Dermatologic 3Classical hematology 3Thoracic 2Plasma cell 1Other solid neoplasm 1Myeloid 1

Conditions

Carcinoma, Non-Small-Cell Lung 6870Lung Neoplasms 5102Small Cell Lung Carcinoma 1166Breast Neoplasms 855Neoplasms 762Colorectal Neoplasms 668Melanoma 566Ovarian Neoplasms 506Neoplasm Metastasis 480Pancreatic Neoplasms 472Adenocarcinoma of Lung 397Stomach Neoplasms 396Prostatic Neoplasms 370Head and Neck Neoplasms 367Carcinoma, Renal Cell 350Esophageal Neoplasms 337Squamous Cell Carcinoma of Head and Neck 325Mesothelioma, Malignant 324Colonic Neoplasms 293Mesothelioma 289Urinary Bladder Neoplasms 262Brain Neoplasms 254Uterine Cervical Neoplasms 243Triple Negative Breast Neoplasms 222Sarcoma 197Endometrial Neoplasms 196Carcinoma, Hepatocellular 186NSCLC 167Pleural Effusion, Malignant 160Kidney Neoplasms 160

Interventions

Sulfonylurea Compounds 1Sodium-Glucose Transporter 2 Inhibitors 1Dipeptidyl-Peptidase IV Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Diabetes Mellitus, Type 2 × Thoracic × Clear all
NCT07332156 2026-01-14

Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas

Samsung Medical Center

Completed
21,692 enrolled
Thoracic

Diabetes Mellitus, Type 2, Disease, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT00782366 2011-04-27

PGT

Mayo Clinic

Completed
26 enrolled
BreastGastrointestinalGenitourinaryOtherThoracic

Atrial Fibrillation, Breast Neoplasms, Celiac Disease, Colonic Neoplasms, Diabetes Mellitus, Type 2, Graves Disease, Lung Neoplasms, Myocardial Infarction, Obesity, Osteoarthritis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡